04 Mar
HIV Drug Given to Protect a Fetus Should be Avoided for One Year After Childbirth (Newswise)
Posted in Menopause Management on 04.03.10 by Merlyn |
A new study finds that while nevirapine works well to prevent mother-to-child HIV transmission, a single dose of nevirapine in infected pregnant women can trigger resistance to some forms of the AIDS-drug cocktail known as combination antiretroviral treatment (ART). This nevirapine-induced resistance fades after about 12 months and no longer hinders ART, say UAB researchers working in Zambia.
Comments Off